No to Acta, yes to the right to health

The United Nations Special Rapporteur on the right to health, Anand Grover, praised the European Parliament’s rejection of the Anti-Counterfeiting Trade Agreement (ACTA) on July 4 as a step in the right direction to ensure continued access to affordable and essential drugs and medication essential for the fulfillment of the right to health

Photo: No to Acta, yes to the right to health
Photo: No to Acta, yes to the right to health

According to Grover, ACTA’s defeat in Europe was a welcome blow to the flawed agreement which had failed to address numerous concerns related to access to medicines. In July 2011, the UN Human Rights Council requested the Special Rapporteur to study existing challenges with regard to access to medicines, ways to overcome them and good practices. He will present the study to the Council in June 2013

10.07.2012

More on the subject:

Related articles

Photo

News • PTB approval for Mako platform

Highest certification for X-ray dosimeter

The RTI Mako achieved one of the highest levels of certification for an X-ray dosimeter with PTB approval, marking a major milestone in the continued evolution of the Mako platform.

Photo

Article • The future of the EU Medical Device Regulation

MDR and IVDR: Navigating the rocky road

Perfectly viable medical devices disappearing from the European market, manufacturers walking away from the EU rather than navigating regulatory demands, patients losing access to products with long,…

Photo

News • Between AI law and patient reality

Do patients have a right to understand health AI?

"Why did the computer conclude this?": Patients increasingly scrutinize the impact of AI on medical diagnostics. A new article explores the tension between transparency and legal frameworks.

Subscribe to Newsletter